Delivery Order SPE2DR25D1104-SPE2DR26FL059
Award Date 1/28/26
Potential Completion Date 1/29/26
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,117.45 to AmerisourceBergen Drug Corp for the supply of Drospirenone-EE 3-0.02 mg tablets (28-count units) on January 27, 2026, with completion expected by January 28, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.56 to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count), a hormonal contraceptive medication. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location....
- The Defense Logistics Agency awarded a $2,816.89 delivery order to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count packaging) on August 21, 2025, with completion scheduled for August 22, 2025. This contract represents a firm fixed-price, competitively awarded delivery order with no set-aside designation. The award was fulfilled by AmerisourceBergen Drug Corp's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,860.04 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of Drospirenone-EE 3-0.02 mg tablets in quantities of 28 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled to be completed by January 28, 2026. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of Amerisourcebergen...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $3,756.98 order is for the delivery of 4563715937 - DROSPIRENONE-EE 3-0.02 MG TAB 28S, a pharmaceutical product, to be delivered by February 21, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, through its Corporate Office division in...
- This is a $1,034.44 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DROSPIRENONE-EE 3-0.02 MG TAB 28S medication, with a performance period ending on May 27, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX. This IDC provides a comprehensive...
- This federal contract award is for the delivery of DROSPIRENONE-EE 3-0.02 MG TAB 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $1,262.04. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,199.45 to AmerisourceBergen Drug Corp for Tri-Lo-Estarylla Tablet 28s, a hormonal contraceptive medication. This firm fixed-price delivery order, issued December 9, 2025, with completion targeted for December 10, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $3,237.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norgestimate-EE 0.25-0.035 mg 28-tablet pack pharmaceutical supplies. The contract was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under a larger indefinite delivery contract vehicle. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 1, 2025, by the Defense Logistics Agency (DLA) for the supply of Loryna 3 mg-0.02 mg tablets in a 28-count package. This firm fixed-price delivery order, valued at $1,450.38, represents a competitive, non-set-aside award and is scheduled for completion by December 2, 2025. The award is issued under AmerisourceBergen's existing Indefinite Delivery...